Trial intelligence / Profile preview

Sodium Thiosulfate for Preservation of Cardiac Function After STEMI

NCT02899364Phase 2Unknown

Sponsor
University Medical Center Groningen
Start
Jul 2018
Primary completion
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Sodium thiosulfate with Placebo (2 arms). Primary endpoint: Myocardial infarct size at 4 months. Status: unknown.

02

Drugs

sodium thiosulfate
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02899364.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02899364.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call